Advertisement
Original article| Volume 40, ISSUE 4, P247-252, August 15, 1996

Lack of effect of laboratory-provoked anxiety on plasma homovanillic acid concentration in normal subjects

  • Zvi Zemishlany
    Correspondence
    Address reprint requests to Zvi Zemishlany, MD, Geha Psychiatric Hospital, P.O. Box 102, Petah Tiqva 49100, Israel.
    Affiliations
    Psychiatry Service, Bronx VA Medical Center, USA

    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Search for articles by this author
  • Michael Davidson
    Affiliations
    Psychiatry Service, Bronx VA Medical Center, USA

    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The present study was undertaken to investigate if acute anxiety can affect plasma concentrations of homovanillic acid (pHVA) Since elevated pHVA levels have been associated with severity of schizophrenic symptoms, the results of this study will help determine if the pHVA elevations are directly related to psychosis or if anxiety is also a contributory factor. Anxiety was provoked in 10 young normal subjects by a combined paradigm of mental arithmetic task and threat of electrical shock. A significant increase in self-ratings of anxiety, blood pressure, and plasma levels of norepinephrine, 3-methoxy-4-hydroxyphenylethyleneglycol and growth hormone indicated that the paradigm used was effective in provoking anxiety; however, anxiety did not affect pHVA concentrations. The results may support the notion that increased pHVA levels in severely ill schizophrenic patients are related to the schizophrenic pathophysiology rather than to anxiety.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abplanalp JM
        • Livingston L
        • Rose RM
        • Sandwisch D
        Cortisol and growth hormone responses to psychological stress during the menstrual cycle.
        Psychosom Med. 1977; 39: 158-177
        • Bacopoulus NG
        • Hattox SE
        • Roth RH
        3,4 dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of dopaminergic activity.
        Eur J Pharmacol. 1979; 56: 225-236
        • Bliss EL
        • Ailion J
        Relationship of stress and activity to brain dopamine and homovanillic acid.
        Life Sci. 1971; 10: 1161-1169
        • Bossert S
        • Berger M
        • Kreig JC
        • Schreiber W
        • Junker M
        • Von Zerssen D
        Cortisol response to various stressful situations: Relationship to personality variables and coping styles.
        Neuropsychobiology. 1988; 20: 36-42
        • Breier A
        Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
        Biol Psychiatry. 1989; 26: 438-462
        • Breier A
        • Wolkowitz OM
        • Rappaport M
        • Paul SM
        • Pickar D
        Metabolic stress effects in normal volunteers and schizophrenic patients.
        Psychopharmacol Bull. 1988; 24: 431-433
        • Breier A
        • Wolkowitz OM
        • Pickar D
        Stress and schizophrenia.
        in: Tamminga CA Schulz SC Advances in Neuropsychiatry and Psychopharmacology, Vol. 1: Schizophrenia Research. Raven Press, London1991: 141-152
        • Brown WA
        • Heninger G
        Cortisol, growth hormone, free fatty acids, and experimentally evoked affective arousal.
        Am J Psychiatry. 1975; 132: 1172-1176
        • Charney DS
        • Heninger GR
        • Breier A
        Noradrenergic function in panic anxiety.
        in: Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry. 41. 1984: 751-763
        • Chattopadhyay P
        • Cooke E
        • Toone B
        • Lader M
        Habituation of physiological responses in anxiety.
        Biol Psychiatry. 1980; 15: 711-721
        • Crawley J
        • Hattox S
        • Maas J
        • Roth RH
        3-methoxy-4-hydroxyphenylethylene-glycol increase in plasma after stimulation of the locus coeruleus.
        Brain Res. 1978; 141: 380-384
        • Dar DE
        • Weizman A
        • Karp L
        • Grinshpoon A
        • Bidder M
        • Kotler M
        • Tyano S
        • Bleich A
        • Gavish M
        Platelet peripheral benzodiazepine receptors in repeated stress.
        Life Sci. 1991; 48: 341-346
        • Davidson M
        • Davis KL
        A comparison of plasma honovanillic acid concentrations in schizophrenic patients and normal controls.
        Arch Gen Psychiatry. 1988; 45: 561-563
        • Davis KL
        • Davidson M
        • Mohs RC
        • Kendler KS
        • Davis BM
        • Johns CA
        • DeNegris Y
        • Horvath TG
        Plasma homovanillic acid concentrations and the severity of schizophrenic illness.
        Science. 1985; 227: 1601-1602
        • Deutch AY
        • Tam SY
        • Roth RH
        Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substania nigra.
        Brain Res. 1985; 333: 143-146
        • Deutch AY
        • Lee MC
        • Gillham MH
        • Cameron DA
        • Goldstein M
        • Iadarola MJ
        Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex.
        CerebCortex. 1991; 1: 273-292
        • Fadda F
        • Argiolas A
        • Melis MR
        • Tissari AH
        • Onali PL
        • Gessa GL
        Stress-induced increase in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in N accumbens: Reversal by diazepam.
        Life Sci. 1978; 23: 2219-2224
        • Gurguis GNM
        • Mefford IN
        • Uhde TW
        Hypothalamic-pituitary-adrenocortical activity in panic disorder: Relationship to plasma catecholamine metabolites.
        Biol Psychiatry. 1991; 30: 502-506
        • Herman JP
        • Guillonneau D
        • Dantzer R
        • Scatton B
        • Semerdjian-Rouquier L
        • Le Moal M
        Differential effects of inescapable foot shocks and of stimuli previously paired with inescapable foot shock on dopamine turnover in cortical and limbic areas of the rat.
        Life Sci. 1982; 30: 2207-2214
        • Johansson GG
        • Karonen SL
        • Laakso ML
        Reversal of an elevated plasma level of prolactin during prolonged psychological stress.
        Acta Physiol Scand. 1983; 119: 463-464
        • Karp L
        • Weizman A
        • Tyano S
        • Gavish M
        Examination stress, platelet peripheral benzodiorepine binding sites, and plasma hormone levels.
        Life Sci. 1989; 44: 1077-1082
        • Kelly D
        • Mitchell-Heggs N
        • Sherman D
        Anxiety and the effects of sodium lactate assessed clinically and physiologically.
        Br J Psychiatry. 1971; 119: 129-141
        • Kendler KS
        • Heninger GR
        • Roth RH
        Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
        Life Sci. 1982; 30: 2063-2069
        • Lavielle S
        • Tassin JP
        • Thierry AM
        • Blanc G
        • Herve D
        • Barthelemy C
        • Glowinski J
        Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat.
        Brain Res. 1978; 168: 585-594
        • Maycock PF
        • Frayn KN
        Use of alumina columns to prepare plasma samples for liquid-chromatographic determinations of catecholamines.
        Clin Chem. 1987; 33: 286-287
        • Pickar D
        • Labarca R
        • Linnoila M
        • Roy A
        • Hommer D
        • Everett D
        • Paul SM
        Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
        Science. 1984; 225: 954-957
        • Pickar D
        • Labarca R
        • Doran AR
        • Wolkowitz OM
        • Roy A
        • Breier A
        • Linnoila M
        • Paul SM
        Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients.
        in: Correlation with psychosis and response to neuroleptic treatment. Arch Gen Psychiatry. 43. 1986: 669-676
        • Pickar D
        • Breier A
        • Hsiao JK
        • Doran AR
        • Wolkowitz OM
        • Pato CN
        • Konicki PE
        • Potter WZ
        Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis.
        in: Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 47. 1990: 641-648
        • Redmond Jr, D
        • Huang Y
        Current concepts: II. New evidence for a locus coeruleus-norepinephrine concentration with anxiety.
        Life Sci. 1979; 25: 2149-2162
        • Rose RM
        Psychoendocrinology.
        in: Wilson JD Foster DW Williams Textbook of Endocrinology. WB Saunders Company, New York1985: 653-681
        • Roth WT
        • Margrat J
        • Ehlers A
        • Haddad HM
        • Maddock RJ
        • Agras WS
        • Taylor CB
        Imipramine and alprazolam effects on stress test reactivity in panic disorder.
        Biol Psychiatry. 1992; 31: 35-51
        • Roy-Byrne PP
        • Uhde TW
        • Sack DA
        • Linnoila M
        • Post RM
        Plasma HVA and anxiety in patients with panic disorder.
        Biol Psychiatry. 1986; 21: 849-853
        • Semple CG
        • Gray CE
        • Borland W
        • Espie CA
        • Beastall GH
        Endocrine effects of examination tests.
        Clin Sci. 1988; 74: 255-259
        • Smith DA
        • Devito JL
        Central neural integration for the control of autonomic responses associated with emotion.
        Ann Rev Neurol Sci. 1984; 7: 43-65
        • Sotsky S
        • Lake C
        • Goodwin F
        Adrenocortical function and plasma norepinephrine in normal human subjects.
        Biol Psychiatry. 1981; 16: 643-651
        • Spielberger CD
        • Gorusch RL
        • Lushene RE
        Manual for the State-Trait-Anxiety.
        Consulting Psychologist Press, Philadelphia1970
        • Suzuki E
        • Kanba S
        • Nibuya M
        • Adachi S
        • Sekiya U
        • Shintani F
        • Kinoshita N
        • Yagi G
        • Asai M
        Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
        Biol Psychiatry. 1994; 36: 654-661
        • Tam SY
        • Roth RH
        Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic betacarboline FG-7142.
        Biochem Pharmacol. 1985; 34: 1595-1598
        • Thierry AM
        • Tassin JP
        • Blanc G
        • Glowinski J
        Selective activation of the mesocortical DA system by stress.
        Nature. 1976; 263: 242-244
        • Uhde TW
        • Siever LJ
        • Post RM
        • Jimerson D
        • Boulenger JP
        • Buchsbaum M
        The relationship of plasma-free MHPG to anxiety and psychophysical pain in normal volunteers.
        Psychopharmacol Bull. 1982; 18: 129-132
        • Uhde TW
        • Boulenger JP
        • Post RM
        • Siever LJ
        • Vittone BJ
        • Jimerson D
        • Roy-Byrne PP
        Fear and anxiety: Relationship to noradrenergic function.
        Psychopathology. 1984; 17: 8-23
        • Yang RK
        • Campbell G
        • Cheng H
        • Tsuboyama GK
        • Davis KL
        Highly sensitive and simple method for determination of free 3-methoxy-4-hydroxyphenylglycol in plasma by high performance liquid chromatography using a Sep-Pak alumina B cartridge.
        J Liq Chromatogr. 1988; 11: 3223-3231